Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Karuna Therapeutics, Inc. | 55,163 | reported | 12 Aug 2020 | tx 6+133,913−50,000 |
| BELLICUM PHARMACEUTICALS, INC | 25,000 | reported | 13 Jun 2019 | tx 4+58,166 |
| INCYTE CORP | 20,853 | reported | 31 Dec 2025 | tx 39+85,888 |
| PhaseBio Pharmaceuticals Inc | 9,750 | reported | 19 May 2023 | tx 9+138,299 |
| ACADIA PHARMACEUTICALS INC | 9,311 | reported | 29 May 2026 | tx 34+270,492−64,648 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 29 May 2026 | EXERCISE | ACADIA PHARMACEUTICALS INC | 8,107 | — | |
| 29 May 2026 | EXERCISE | ACADIA PHARMACEUTICALS INC | 8,107 | 0.00 USD | deriv |
| 29 May 2026 | GRANT_AWARD | ACADIA PHARMACEUTICALS INC | 16,004 | 0.00 USD | deriv |
| 29 May 2026 | GRANT_AWARD | ACADIA PHARMACEUTICALS INC | 9,311 | 0.00 USD | deriv |
| 31 Dec 2025 | GRANT_AWARD | INCYTE CORP | 245 | 98.77 USD | |
| 30 Sept 2025 | GRANT_AWARD | INCYTE CORP | 289 | 84.81 USD | |
| 30 Jun 2025 | GRANT_AWARD | INCYTE CORP | 367 | 68.10 USD | |
| 10 Jun 2025 | GRANT_AWARD | INCYTE CORP | 2,518 | 0.00 USD | |
| 10 Jun 2025 | GRANT_AWARD | INCYTE CORP | 9,216 | 0.00 USD | deriv |
| 29 May 2025 | EXERCISE | ACADIA PHARMACEUTICALS INC | 9,387 | — | |
| 29 May 2025 | GRANT_AWARD | ACADIA PHARMACEUTICALS INC | 13,793 | 0.00 USD | deriv |
| 29 May 2025 | GRANT_AWARD | ACADIA PHARMACEUTICALS INC | 8,107 | 0.00 USD | deriv |
| 29 May 2025 | EXERCISE | ACADIA PHARMACEUTICALS INC | 9,387 | 0.00 USD | deriv |
| 31 Mar 2025 | GRANT_AWARD | INCYTE CORP | 363 | 60.55 USD | |
| 31 Dec 2024 | GRANT_AWARD | INCYTE CORP | 339 | 69.07 USD | |
| 30 Sept 2024 | GRANT_AWARD | INCYTE CORP | 378 | 66.10 USD | |
| 28 Jun 2024 | GRANT_AWARD | INCYTE CORP | 409 | 60.62 USD | |
| 12 Jun 2024 | GRANT_AWARD | INCYTE CORP | 2,830 | 0.00 USD | |
| 12 Jun 2024 | GRANT_AWARD | INCYTE CORP | 12,517 | 0.00 USD | deriv |
| 29 May 2024 | EXERCISE | ACADIA PHARMACEUTICALS INC | 6,652 | — | |
| 29 May 2024 | GRANT_AWARD | ACADIA PHARMACEUTICALS INC | 9,387 | 0.00 USD | deriv |
| 29 May 2024 | GRANT_AWARD | ACADIA PHARMACEUTICALS INC | 15,959 | 0.00 USD | deriv |
| 29 May 2024 | EXERCISE | ACADIA PHARMACEUTICALS INC | 6,652 | 0.00 USD | deriv |
| 28 Mar 2024 | GRANT_AWARD | INCYTE CORP | 413 | 56.97 USD | |
| 29 Dec 2023 | GRANT_AWARD | INCYTE CORP | 423 | 62.79 USD |
1 purchase reported after at least 12 months of silence — most recent on 03 Dec 2020.